Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada (Q51137084)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 September 2009

edit

Language	Label	Description	Also known as
English	Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada	scientific article published on 26 September 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

title

Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

main subject

Canada

0 references

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

author name string

Béatrice Poirier

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

Philippe De Wals

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

Geneviève Petit

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

Lonny J Erickson

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

Jacques Pépin

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

language of work or name

English

0 references

publication date

26 September 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

published in

Vaccine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

volume

27

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

issue

50

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

page(s)

7105-7109

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

cites work

Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Epidemiological and economic burden of pneumococcal diseases in Canadian children

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Bacteremic pneumococcal pneumonia: a prospective study in Edmonton and neighboring municipalities

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.057

retrieved

7 January 2021

Identifiers

DOI

10.1016/J.VACCINE.2009.09.057

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

PubMed publication ID

19786137

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19786137

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/19786137

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51137084&oldid=2268699529"